CS

Chen Singh

Active Director Director DIN 09607759
DIN 09607759 First appointment Jun 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Chen Singh

Data last updated:

Chen Singh is a Director at Shree Numen Health Care Private Limited (since 2022). The company operates in Healthcare. Shree Numen Health Care Private Limited reported revenue of ₹1.28 Cr (FY 2020).

DIN 09607759
Primary Designation Director
Industry Healthcare
First Appointment 30 Jun 2022
Oldest Company Age 13 yrs
Largest company Shree Numen Health Care Private Limited · ₹1.28 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jun 20222013₹1.28 Cr (FY 2020)Active

Board colleagues of Chen Singh

NameDINCompanyDesignation
Mahesh Singh09289102Shree Numen Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shree Numen Health Care Private Limited
Premium access

Shareholding and investment profile for Chen Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chen Singh

Chen Singh currently holds 1 directorship: Shree Numen Health Care Private Limited (Director, since 30 Jun 2022, revenue ₹1.28 Cr (FY 2020)).

Chen Singh was first appointed on 30 Jun 2022 as Director at Shree Numen Health Care Private Limited.

The current boards of Chen Singh's companies include Mahesh Singh (Shree Numen Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available